(continued)
- Avmapki Fakzynja Co-Pack (avutometinib and defactinib)
- Emrelis (telisotuzumab vedotin-tllv)
- Tryptyr (acoltremon)
- Vyloy (zolbetuximab-clzb)
- Zynrelef (bupivacaine/meloxicam)
- Exparel (bupivacaine)
- Ropivacaine (Naropin)
- Ohtuvayre (ensifentrine)
- Voydeya (danicopan)
- Myhibbin (mycophenolate mofetil)
- Vevye (cyclosporine ophthalmic)
- Augtyro (repotrectinib)
- Talvey (talquetamab-tgvs)
- Akeega (niraparib/abiraterone)
- Brixadi (buprenorphine)
- Miebo (perfluorohexyloctane)
- Zynyz (retifanlimab-dlwr)
- Rezlidhia (olutasidenib)
- Adbry (tralokinumab-ldrm)
- Ngenla (somatrogon-ghla)
- Hyftor (sirolimus)
- Opsynvi (macitentan/tadalafil)
- Pilocarpine ophthalmic
- Opzelura (ruxolitinib)
- Welireg (belzutifan)
- Tivdak (Tisotumab-Vedotin-Tftv)
- Onureg (azacitidine)
- Gavreto (pralsetinib)
- Monjuvi (tafasitamab-cxix)
- Mycapssa (Octreotide)
- Saphnelo for Lupus
- Adbry for Atopic Dermatitis: What You Need to Know
- Treating Breast Cancer with Trodelvy – What You Need to Know
- Navigating Psoriasis With Otezla: What You Need to Know
- Navigating Psoriatic Arthritis With Otezla: What You Need to Know
- Myfembree for Uterine Fibroids and Endometriosis
- Caplyta for Schizophrenia and Bipolar Depression